TRPC5 and breast cancer: It is possible that the observed reduction in receptor-operated Ca2+ signaling, an indirect measure of TRPC5 activity in breast cancer cells, represents a negative feedback mechanism geared towards reducing chronic Gd3+-dependent stimulation of TRPC5 activity.